Registered indexed-linked annuity (RILA) sales soared to $47.4 billion in 2023. Teodor Panaitisor, LIMRA assistant research director of annuity research, discusses the RILA product market and its expected growth. InsuranceNewsNet: RILAs take off as consumers look for balance, protection: https://ow.ly/n3mK50SEhI9 #Annuities #MarketGrowth
LIMRA’s Post
More Relevant Posts
-
Servant Leader | Unapologetically Passionate | Advocate and Ambassador to the Financial Services Industry
Total U.S. annuity sales reached $133.5 billion in the first quarter, according to LIMRA's preliminary annuity sales results. This is the highest first-quarter sales ever recorded. Bryan Hodgens, head of LIMRA research, cited favorable economic conditions and growing consumer interest as key factors in the record sales. LIMRA: U.S. Annuity Sales Surge to Strongest First Quarter Ever: https://lnkd.in/eb7yCgmF #AnnuitySales #Annuities #IncomeProtection #FinancialServices LIMRA
To view or add a comment, sign in
-
Access the summary report on variable annuity behavior from the SOA and LIMRA Experience Studies Pro. Learn about this study on 2019-2021 analysis and how to purchase the data package. https://bit.ly/3QIsOfT. #actuaries #actuaryresearch #annuities
To view or add a comment, sign in
-
It's not easy navigating new IRA pricing.
Bristol Myers CEO 'increasingly confident' company can handle IRA pricing on Eliquis
fiercepharma.com
To view or add a comment, sign in
-
Updated Draft of the 2024 Variable Insurance Product (VIP) Taxonomy The Commission amended Form N-4 to require issuers of registered index-linked annuities (RILAs) to register offerings on Form N-4. It also extended registration, filing, and disclosure rules for RILAs to registered market value adjustment (MVA) annuities. See https://lnkd.in/g85Sbjr8. Issuers of RILAs and registered MVA annuities must now tag certain data in Inline XBRL format and file electronically via EDGAR. These new elements are part of the VIP taxonomy, as both products are registered on Form N-4. #SEC #RILA #MVAAnnuities #FormN4 #XBRL #EDGAR #FinancialRegulation #Annuities #Compliance #InsuranceProducts https://lnkd.in/gx3iKZYT
To view or add a comment, sign in
-
5.05% FDA will DECREASE - Take Advantage! Annuity FDA Rates will decrease next week! Take advantage of the 5.05% guaranteed rate on our Secure Term MVA Fixed Annuity (guaranteed for 3 years, based on a $100,000 premium). Please see the attached flyer for important information: Fixed Deferred Annuity - Rates
To view or add a comment, sign in
-
Total U.S. annuity sales were $215.2 billion in the first half of 2024, a 19% jump from prior year results, according to preliminary results from LIMRA’s U.S. Individual Annuity Sales Survey. This is a new sales record for the first six months of a year since LIMRA started tracking sales in the 1980s. ➡️LIMRA: U.S. Annuity Sales Set New Record in First Half of 2024 https://ow.ly/16ee50SJfnc #Annuities #FinancialServices #AnnuityMarket
To view or add a comment, sign in
-
Member at Forbes Finance Council | The MOST Connected Person in Life Insurance & Annuities | Relationship-Builder | Annuity Expert | Life Insurance Expert | Distribution Pro | Strategy Diva | Competitive Intel Guru
Ooohhh...let's talk about Brett A. Blake's new Change.org petition. Who's in his crosshairs? *************************FMOs that won't release.************************* My understanding is that most FMOs will provide a release. After all- who wants a disgruntled agent that won't write business with them? But Brett is trying to build an empire, and running into firms that won't release. What do you think? Should insurance companies allow agents to write business with a new FMO, without a release? #FMOs #Distribution #Annuities #AnnuityDotCom #IntelRockstar https://lnkd.in/e4KqrKwg
To view or add a comment, sign in
-
Middle market life sciences companies remain optimistic about several areas of expansion in the next 12 months. Despite concerns of changes in leaders and recession, 80% of life sciences companies plan to introduce a new product or service. More on middle market life sciences trends: https://bit.ly/4brETyQ
Middle Market Indicator: Life Sciences Industry Spotlight
chubb.com
To view or add a comment, sign in
-
Middle market life sciences companies remain optimistic about several areas of expansion in the next 12 months. Despite concerns of changes in leaders and recession, 80% of life sciences companies plan to introduce a new product or service. More on middle market life sciences trends: https://bit.ly/4brETyQ
Middle Market Indicator: Life Sciences Industry Spotlight
chubb.com
To view or add a comment, sign in
-
Middle market life sciences companies remain optimistic about several areas of expansion in the next 12 months. Despite concerns of changes in leaders and recession, 80% of life sciences companies plan to introduce a new product or service. More on middle market life sciences trends: https://bit.ly/4brETyQ
Middle Market Indicator: Life Sciences Industry Spotlight
chubb.com
To view or add a comment, sign in
26,912 followers